| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.001 |